Clinical Trials Logo

Clinical Trial Summary

The purpose of the study:1.Improve the understanding of the risk factors of pulmonary cryptococcosis;2.Improve the awareness of pulmonary cryptococcosis clinical and imaging manifestations;3.Grasp pulmonary cryptococcosis patients of clinical and imaging manifestations in different conditions;4.Learn about antibacterial activity of antifungal drugs for cryptococcosis in China.


Clinical Trial Description

1. Patients corresponding to inclusion criteria and obtaining informed consent are included in the research in department of respiration ward in cooperative hospitals.

2. Relevant case report forms are created in this study.

3. Basic information such as age,weight and height is recorded in selected cases.Clinical manifestations,risk factors,laboratory examination,imaging examination,etiological examination and histopathological examination are also recorded in selected cases by case report forms.In addition,antifungal treatment is recorded including name,dose,time of starting treatment and terminate treatment.Causes of terminate treatment and curative effect evaluation should be analysed.

4. Statistical analysis. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02503449
Study type Observational [Patient Registry]
Source Chinese PLA General Hospital
Contact
Status Enrolling by invitation
Phase N/A
Start date December 2014
Completion date December 2017

See also
  Status Clinical Trial Phase
Recruiting NCT02454569 - Vicente Ferrer HIV Cohort Study
Recruiting NCT04033718 - Inpatient Package to Reduce HIV and AIDS-related Death in Zambia N/A
Terminated NCT03002012 - Cryptococcal Antigen Screening Plus Sertraline Phase 3
Completed NCT03993093 - Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre
Completed NCT05707156 - Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
Completed NCT00001701 - Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection N/A
Completed NCT01535469 - Operational Research for Cryptococcal Antigen Screening Phase 4
Completed NCT00784368 - A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection Phase 3
Recruiting NCT04554875 - Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules
Active, not recruiting NCT03267407 - Vietnam Cryptococcal Retention in Care Study - Version 2.1 N/A
Completed NCT00647907 - A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections Phase 4
Recruiting NCT00001352 - Fungal Infection Susceptibility